In 2022, BMO Ride for Cancer will play a monumental role in introducing a first-in-the-world cancer-fighting technology, called personalized radiotherapy, at the QEII Health Sciences Centre.
This technology has the potential to target radiation beams like never before; completely personalized based on the shape and movement of a patient’s tumour and anatomy mere minutes before their treatment begins. This technology aims to reduce the number of treatment sessions from 25 to five for certain cancers, improve cancer outcomes, lessen treatment side effects, and ensure more patients spend less time in hospital and more time at home with their families.
This project will be entirely donor-funded through BMO Ride for Cancer and the QEII Foundation. It will truly take an army of supporters – including riders, donors, community partners and more – to bring this world-leading project to the finish line.